{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:48:11Z","timestamp":1792172891971,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Mevalonate kinase deficiency (MKD) is a rare autoinflammatory syndrome. Several reports have described allogeneic hematopoietic stem cell transplantation in severely affected patients, sometimes with promising results. In view of the scarcity of data, this study aims to analyse the efficacy and safety of allogeneic hematopoietic stem cell transplantation (HSCT) to give a more complete overview of this treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicentre retrospective study on behalf of the European Society for Blood and Marrow Transplantation aimed to include all MKD patients who had undergone allogeneic HSCT. All centres related to EMBT and centres that have reported cases of allogeneic HSCT in the literature were contacted via the EBMT data office.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We analyzed 9 patients (5 male). Treosulfan based conditioning was the most frequently used conditioning regimen. Engraftment occurred in all but one patient. Source of stem cells was cord blood (<jats:italic>n<\/jats:italic>\u00a0=\u20092), peripheral blood stem cells (<jats:italic>n<\/jats:italic>\u00a0=\u20094) and bone marrow (<jats:italic>n<\/jats:italic>\u00a0=\u20095). Two patients needed a second transplantation due to an incomplete response or primary graft failure. Seven patients went into complete remission after stem cell transplantation. At final follow-up these patients reported no symptoms of MKD.<\/jats:p>\n                <jats:p>Four patients suffered from grade II-IV acute graft-versus-host disease (GvHD). During follow-up two patients died due to transplantation related complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, allogeneic stem cell transplantation represents an effective treatment for the most severely affected MKD patients. However, treatment-related morbidity and mortality are significant. Transplantation may be justified in patients with a severe disease course on conservative therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00716-4","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:18:12Z","timestamp":1659100692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-0576","authenticated-orcid":false,"given":"Jerold","family":"Jeyaratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Drabko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiarlan","family":"Sirait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EBMT Inborn Errors Working Party","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","volume":"323","author":"JM Van Der Meer","year":"1984","unstructured":"Van Der Meer JM, Vossen JM, Radl J, et al. Hyperimmunoglobulinemia D and periodic fever : a new syndrome. Lancet. 1984;323:1087\u201390.","journal-title":"Lancet"},{"key":"716_CR2","first-page":"163","volume":"60","author":"AM Prieur","year":"1984","unstructured":"Prieur AM, Griscelli C. Nosologic aspects of systemic forms of very-early-onset juvenile arthritis. Apropos of 17 cases. La semaine des hopitaux. 1984;60:163.","journal-title":"La semaine des hopitaux"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1542\/peds.2010-3639","volume":"128","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Florkin B, Sibilia J, et al. Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics (Evanston). 2011;128:e152\u20139. https:\/\/doi.org\/10.1542\/peds.2010-3639.","journal-title":"Pediatrics (Evanston)"},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","volume":"147","author":"R van der Burgh","year":"2013","unstructured":"van der Burgh R, ter Haar NM, Boes ML, et al. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol (Orlando, Fla). 2013;147:197\u2013206. https:\/\/doi.org\/10.1016\/j.clim.2012.09.011.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"716_CR5","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","volume":"68","author":"NM ter Haar","year":"2016","unstructured":"ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry. Arthrit Rheumatol (Hoboken, NJ). 2016;68:2795\u2013805. https:\/\/doi.org\/10.1002\/art.39763.","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"key":"716_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N ter Haar","year":"2013","unstructured":"ter Haar N, Lachmann H, \u00d6zen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever registry and a literature review. Ann Rheum Dis. 2013;72:678\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201268.","journal-title":"Ann Rheum Dis"},{"key":"716_CR7","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/nejmoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018;378:1908\u201319. https:\/\/doi.org\/10.1056\/nejmoa1706314.","journal-title":"N Engl J Med"},{"key":"716_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/md.0b013e318190cfb7","volume":"87","author":"JC van der Hilst","year":"2008","unstructured":"van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with Hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87:301\u201310. https:\/\/doi.org\/10.1097\/md.0b013e318190cfb7.","journal-title":"Medicine (Baltimore)"},{"key":"716_CR9","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SHL Mandey","year":"2006","unstructured":"Mandey SHL, Kuijk LM, Frenkel J, et al. A role for geranylgeranylation in interleukin-1\u03b2 secretion. Arthrit Rheum. 2006;54:3690\u20135. https:\/\/doi.org\/10.1002\/art.22194.","journal-title":"Arthrit Rheum"},{"key":"716_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJMc072018","volume":"357","author":"PD Arkwright","year":"2007","unstructured":"Arkwright PD, Abinun M, Cant AJ. Mevalonic aciduria cured by bone marrow transplantation. N Engl J Med. 2007;357:1350. https:\/\/doi.org\/10.1056\/NEJMc072018.","journal-title":"N Engl J Med"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1056\/NEJMoa070715","volume":"356","author":"B Neven","year":"2007","unstructured":"Neven B, Valayannopoulos V, Quartier P, et al. Allogeneic bone marrow transplantation in Mevalonic aciduria. N Engl J Med. 2007;356:2700\u20133. https:\/\/doi.org\/10.1056\/NEJMoa070715.","journal-title":"N Engl J Med"},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00296-016-3456-9","volume":"36","author":"S Erdol","year":"2016","unstructured":"Erdol S, Cekic S, K\u0131l\u0131c SC, et al. Massive ascites in a canakinumab resistant case with MVA leading to bone marrow transplantation. Rheumatol Int. 2016;36:1011\u20133. https:\/\/doi.org\/10.1007\/s00296-016-3456-9.","journal-title":"Rheumatol Int"},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.21873\/anticanres.11483","volume":"37","author":"S Nassereddine","year":"2017","unstructured":"Nassereddine S, Rafei H, Elbahesh E, et al. Acute graft versus host disease: a comprehensive review. Anticancer Res. 2017;37:1547\u201355. https:\/\/doi.org\/10.21873\/anticanres.11483.","journal-title":"Anticancer Res"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41409-020-0826-4","volume":"55","author":"JR Passweg","year":"2020","unstructured":"Passweg JR, Baldomero H, Chabannon C, et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus. Bone Marrow Transplant. 2020;55:1604\u201313. https:\/\/doi.org\/10.1038\/s41409-020-0826-4.","journal-title":"Bone Marrow Transplant"},{"key":"716_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14397595.2018.1442639","volume":"29","author":"T Tanaka","year":"2019","unstructured":"Tanaka T, Yoshioka K, Nishikomori R, et al. National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics. Modern Rheumatol. 2019;29:181\u20137. https:\/\/doi.org\/10.1080\/14397595.2018.1442639.","journal-title":"Modern Rheumatol"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1542\/peds.2014-2553","volume":"135","author":"S Giardino","year":"2015","unstructured":"Giardino S, Lanino E, Morreale G, et al. Long-term outcome of a successful cord blood stem cell transplant in mevalonate kinase deficiency. Pediatrics (Evanston). 2015;135:e211\u20135. https:\/\/doi.org\/10.1542\/peds.2014-2553.","journal-title":"Pediatrics (Evanston)"},{"key":"716_CR17","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1093\/rheumatology\/keaa912","volume":"60","author":"M Faraci","year":"2021","unstructured":"Faraci M, Giardino S, Podest\u00e0 M, et al. Haploidentical \u03b1\/\u03b2 T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency. Rheumatology (Oxford, England). 2021;60:4850\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/keaa912.","journal-title":"Rheumatology (Oxford, England)"},{"key":"716_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/TCRM.S195538","volume":"17","author":"H Yildiz","year":"2021","unstructured":"Yildiz H, Bailly S, Van Den Neste E, et al. Clinical Management of Relapsed\/refractory Hemophagocytic Lymphohistiocytosis in adult patients: a review of current strategies and emerging therapies. Ther Clin Risk Manag. 2021;17:293\u2013304. https:\/\/doi.org\/10.2147\/TCRM.S195538.","journal-title":"Ther Clin Risk Manag"},{"key":"716_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1182\/blood-2002-02-0651","volume":"100","author":"J Milledge","year":"2002","unstructured":"Milledge J, Shaw PJ, Mansour A, et al. Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood. 2002;100:774\u20137. https:\/\/doi.org\/10.1182\/blood-2002-02-0651.","journal-title":"Blood"},{"key":"716_CR20","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, M\u00fcller I, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130:2682\u20138. https:\/\/doi.org\/10.1182\/blood-2017-07-798660.","journal-title":"Blood"},{"key":"716_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/annrheumdis-2020-218695","volume":"80","author":"T Mori","year":"2021","unstructured":"Mori T, Saburi M, Hagihara M, et al. Long-term remission of cryopyrin-associated periodic syndrome after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis. 2021;80:542\u20133. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218695.","journal-title":"Ann Rheum Dis"},{"issue":"250","key":"716_CR22","doi-asserted-by":"publisher","first-page":"255.e1","DOI":"10.1016\/j.jaci.2020.11.043","volume":"148","author":"A Laberko","year":"2021","unstructured":"Laberko A, Burlakov V, Maier S, et al. HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome. J Allergy Clin Immunol. 2021;148(250):255.e1. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.043.","journal-title":"J Allergy Clin Immunol"},{"key":"716_CR23","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s10875-021-01124-1","volume":"41","author":"M Shiraki","year":"2021","unstructured":"Shiraki M, Williams E, Yokoyama N, et al. Hematopoietic cell transplantation ameliorates autoinflammation in A20 Haploinsufficiency. J Clin Immunol. 2021;41:1954\u20136. https:\/\/doi.org\/10.1007\/s10875-021-01124-1.","journal-title":"J Clin Immunol"},{"key":"716_CR24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/j.1600-6143.2011.03989.x","volume":"12","author":"S Chaudhury","year":"2012","unstructured":"Chaudhury S, Hormaza L, Mohammad S, et al. Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical Mevalonic aciduria. Am J Transplant. 2012;12:1627\u201331. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03989.x.","journal-title":"Am J Transplant"},{"key":"716_CR25","doi-asserted-by":"publisher","first-page":"e13604","DOI":"10.1111\/petr.13604","volume":"24","author":"AM Szymanski","year":"2020","unstructured":"Szymanski AM, D\u00e1vila Salda\u00f1a B, Ferreira CR, et al. Mevalonic aciduria: does stem cell transplant fully cure disease? Pediatr Transplant. 2020;24:e13604. https:\/\/doi.org\/10.1111\/petr.13604.","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00716-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:22:05Z","timestamp":1659100925000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00716-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00716-4","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"the study was conducted according to EBMT guidelines and the principles of Helsinki. If necessary, additional ethical approval was obtained according to local guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}